Wellcome Trust’s Accenture ACN Stock Holding History

Wellcome Trust’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$137M	Hold	1,100,000	–	–	1.52%	17
2026 Q1	$218M	Hold	1,100,000	–	–	2.69%	17
2025 Q4	$295M	Hold	1,100,000	–	–	3.17%	16
2025 Q3	$271M	Hold	1,100,000	–	–	2.95%	17
2025 Q2	$329M	Hold	1,100,000	–	–	3.79%	13
2025 Q1	$343M	Hold	1,100,000	–	–	4.29%	11
2024 Q4	$387M	Hold	1,100,000	–	–	4.67%	9
2024 Q3	$389M	Hold	1,100,000	–	–	4.73%	9
2024 Q2	$334M	Hold	1,100,000	–	–	4.27%	10
2024 Q1	$381M	Hold	1,100,000	–	–	4.58%	9
2023 Q4	$386M	Hold	1,100,000	–	–	4.78%	9
2023 Q3	$338M	Hold	1,100,000	–	–	4.49%	10
2023 Q2	$339M	Hold	1,100,000	–	–	4.47%	11
2023 Q1	$314M	Hold	1,100,000	–	–	4.39%	11
2022 Q4	$294M	Hold	1,100,000	–	–	4.34%	11
2022 Q3	$283M	Hold	1,100,000	–	–	4.44%	9
2022 Q2	$305M	Hold	1,100,000	–	–	3.98%	14
2022 Q1	$371M	Hold	1,100,000	–	–	3.88%	11
2021 Q4	$456M	Hold	1,100,000	–	–	4.33%	8
2021 Q3	$352M	Hold	1,100,000	–	–	3.48%	17
2021 Q2	$324M	Hold	1,100,000	–	–	3.09%	18
2021 Q1	$304M	Hold	1,100,000	–	–	3.17%	16
2020 Q4	$287M	Hold	1,100,000	–	–	2.94%	15
2020 Q3	$249M	Hold	1,100,000	–	–	3.36%	16
2020 Q2	$236M	Buy	1,100,000 +830,000	+307%	+$157M	3.59%	15
2020 Q1	$44.1M	Buy	+270,000	New	+$52M	0.79%	19

Other funds holding ACN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellcome Trust's ACN Position: Q2 2026 in Review

Wellcome Trust held its Accenture (ACN) position steady in Q2 2026 at 1,100,000 shares worth $137M. The position accounts for 1.52% of the portfolio, ranked #17.

Wellcome Trust first reported a position in ACN in Q1 2020 and has held it in 26 quarters since. The position peaked at $456M in Q4 2021. 1,893 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

Wellcome Trust held 1,100,000 shares of Accenture worth $137M as of Q2 2026.
Wellcome Trust left its Accenture share count unchanged in Q2 2026.
Accenture made up 1.52% of Wellcome Trust's portfolio in Q2 2026, its #17 holding.
Wellcome Trust first reported a position in Accenture in Q1 2020 and has held it in 26 quarters since.
Wellcome Trust's Accenture position peaked at $456M in Q4 2021.
1,893 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.